Jennifer Pearson is an Associate Professor in Health Administration and Policy in the School of Public Health at the University of Nevada, Reno. Broadly, her research focuses on how regulation of tobacco and cannabis product characteristics, packaging, and advertising affects consumer behavior and public health outcomes. Dr. Pearson has authored over 100 scientific peer-reviewed scientific… Read more »
Stefanie Miller is an investment analyst with FiscalNote Markets in Washington, D.C., where she leads the tobacco, cannabis, politics and fiscal policy practice areas. She specializes in the legal and political risks to the tobacco sector stemming from FDA tobacco regulations, Congressional tobacco control efforts, innovative products entering the nicotine market, and incumbent public health… Read more »
Dr. Ahluwalia is a physician, public health scientist and professor at Brown University’s Schools of Public Health and Medicine, and is the Associate Director for Population Sciences at the Brown Cancer Center. He has been in academic medicine since 1992 and has been a practicing physician, faculty member, department chair, Associate Dean and Center Director in medical… Read more »
Matthew R. Holman, Ph.D. is currently Director of the Office of Science at the Center for Tobacco Products (CTP) of the U.S. Food and Drug Administration (FDA). He was appointed to that position in January 2017. The Office of Science at CTP is responsible for identifying, developing, and enhancing the science related to tobacco products,… Read more »
Richard Miech is a Research Professor at the University of Michigan’s Institute for Social Research and Principal Investigator of Monitoring the Future. He received his Ph.D. degree in Sociology from the University of North Carolina at Chapel Hill and a MPH degree from Johns Hopkins University. His work focuses on trends in substance use, with… Read more »
Andrew Hyland is the Chair of the Department of Health Behavior at Roswell Park Comprehensive Cancer Center and the Scientific Principal Investigator of the Population Assessment of Tobacco and Health (PATH) Study, which is supported by the National Institute on Drug Abuse and the Food and Drug Administration to study more than 46,000 adults and… Read more »
David Graham is Chief Impact Officer at NJOY, a role which leads efforts across the company to maximize the positive impact on public health of the company’s products and services through increasing their reach and effectiveness while including oversight of regulatory affairs for the company. He has extensive experience in nicotine and non-nicotine new product… Read more »
Prof Cummings is a Professor in the Department of Psychiatry & Behavioral Sciences at the Medical University of South Carolina where he co-leads the tobacco control research program. Over his nearly 40 year public health career he has published over 620 scientific papers on a wide range of topics including studies evaluating methods for smoking… Read more »
Neal L. Benowitz, MD, is Emeritus Professor of Medicine in the Research Program in Clinical Pharmacology, Division of Cardiology, at the University of California, San Francisco (UCSF). He was Chief of the Division of Clinical Pharmacology and Experimental Therapeutics at UCSF for 35 years. He received his medical degree from the University of Rochester School… Read more »
David Levy has a PhD in Economics from UCLA and is currently a Professor of Oncology at Georgetown. He has published over 300 papers, including articles in the American Economic Review, American Journal of Public Health, JAMA, Lancet, Medical Care, American Journal of Preventive Medicine, Tobacco Control, Nicotine and Tobacco Research and the Review of… Read more »
Recent Comments